Historical source coverage

2011

45 selected records with a cited source date in 2011. This archive is selective and does not imply continuous monitoring or complete historical coverage.

Explore 2011 by record type

3 types

December 2011

3 records

Clinical trials · Cerebrolysin

ClinicalTrials.gov record NCT01388738

PeptideScanner retained ClinicalTrials.gov record NCT01388738 at 2026-11-16T17:33:14.861Z. Its registry update date was 2011-12-23, and PeptideScanner's reviewed identity mapping was cerebrolysin.

Source: ClinicalTrials.gov ↗

→

November 2011

5 records

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00557310

PeptideScanner retained ClinicalTrials.gov record NCT00557310 at 2026-07-30T22:15:58.883Z. Its registry update date was 2011-11-11, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Bivalirudin

ClinicalTrials.gov record NCT00073593

PeptideScanner retained ClinicalTrials.gov record NCT00073593 at 2026-11-15T21:58:19.888Z. Its registry update date was 2011-11-10, and PeptideScanner's reviewed identity mapping was bivalirudin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Bivalirudin

ClinicalTrials.gov record NCT00503126

PeptideScanner retained ClinicalTrials.gov record NCT00503126 at 2026-11-15T21:58:19.888Z. Its registry update date was 2011-11-10, and PeptideScanner's reviewed identity mapping was bivalirudin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Desmopressin

ClinicalTrials.gov record NCT01078753

PeptideScanner retained ClinicalTrials.gov record NCT01078753 at 2026-11-16T01:33:21.554Z. Its registry update date was 2011-11-02, and PeptideScanner's reviewed identity mapping was desmopressin.

Source: ClinicalTrials.gov ↗

→

October 2011

5 records

Regulatory · Peginesatide

Federal Register notice 2011-27327

The Federal Register published notice 2011-27327, attributed to FDA and its parent HHS department, on 2011-10-24. Its official title is “Oncologic Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Peginesatide.

Source: Federal Register via GovInfo ↗

→

Clinical trials · Glatiramer acetate

ClinicalTrials.gov record NCT00337779

PeptideScanner retained ClinicalTrials.gov record NCT00337779 at 2026-11-16T17:42:50.457Z. Its registry update date was 2011-10-10, and PeptideScanner's reviewed identity mapping was glatiramer-acetate.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Secretin

Structural insights into RAMP modification of secretin family G protein-coupled receptors: implications for drug development.

PubMed lists PMID 21722971 in Trends in pharmacological sciences as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2011-06-29 (day precision). PeptideScanner associated the retained record with the identity slug secretin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

September 2011

1 record

Clinical trials · Bivalirudin

ClinicalTrials.gov record NCT00043940

PeptideScanner retained ClinicalTrials.gov record NCT00043940 at 2026-11-15T21:58:19.888Z. Its registry update date was 2011-09-16, and PeptideScanner's reviewed identity mapping was bivalirudin.

Source: ClinicalTrials.gov ↗

→

August 2011

1 record

July 2011

2 records

June 2011

6 records

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00761332

PeptideScanner retained ClinicalTrials.gov record NCT00761332 at 2026-07-30T22:15:58.887Z. Its registry update date was 2011-06-21, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Thymosin alpha-1

ClinicalTrials.gov record NCT00711620

PeptideScanner retained ClinicalTrials.gov record NCT00711620 at 2026-11-15T22:10:40.222Z. Its registry update date was 2011-06-14, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

Source: ClinicalTrials.gov ↗

→

Regulatory · Leuprolide

Federal Register notice 2011-14164

The Federal Register published notice 2011-14164, attributed to FDA and its parent HHS department, on 2011-06-08. Its official title is “Bristol-Myers Squibb Co. et al.; Withdrawal of Approval of 70 New Drug Applications and 97 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide.

Source: Federal Register via GovInfo ↗

→

May 2011

11 records

Literature metadata · Lanreotide

PubMed record PMID 21607321

PeptideScanner retained PubMed bibliographic metadata for PMID 21607321 at 2026-07-30T22:17:00.088Z. PubMed recorded a metadata revision date of 2011-05-24 and an Entrez history date of 2011-05-25. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Regulatory · Icatibant

Federal Register notice 2011-12543

The Federal Register published notice 2011-12543, attributed to FDA and its parent HHS department, on 2011-05-23. Its official title is “Pulmonary-Allergy Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Icatibant.

Source: Federal Register via GovInfo ↗

→

April 2011

4 records

Literature metadata · Humanin

Humanin signal for Alzheimer's disease.

PubMed lists PMID 21335658 in Journal of Alzheimer's disease : JAD as Journal Article, Review, with publication-date metadata of 2011 (year precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00439244

PeptideScanner retained ClinicalTrials.gov record NCT00439244 at 2026-07-30T22:15:58.884Z. Its registry update date was 2011-04-20, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Desmopressin

ClinicalTrials.gov record NCT00902265

PeptideScanner retained ClinicalTrials.gov record NCT00902265 at 2026-11-16T01:33:21.554Z. Its registry update date was 2011-04-19, and PeptideScanner's reviewed identity mapping was desmopressin.

Source: ClinicalTrials.gov ↗

→

March 2011

3 records

Literature metadata · Emideltide

PubMed record PMID 21262293

PeptideScanner retained PubMed bibliographic metadata for PMID 21262293 at 2026-07-30T22:17:00.064Z. PubMed recorded a metadata revision date of 2011-03-18 and an Entrez history date of 2011-01-26. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

February 2011

2 records

Clinical trials · Bremelanotide

ClinicalTrials.gov record NCT00425256

PeptideScanner retained ClinicalTrials.gov record NCT00425256 at 2026-07-30T22:15:58.882Z. Its registry update date was 2011-02-23, and PeptideScanner's reviewed identity mapping was bremelanotide.

Source: ClinicalTrials.gov ↗

→

January 2011

2 records

Literature metadata · Secretin

Secretin and body fluid homeostasis.

PubMed lists PMID 20944548 in Kidney international as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2010-10-13 (day precision). PeptideScanner associated the retained record with the identity slug secretin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→